Hydroxychloroquine combination risky for cancer patients with COVID-19: Study

US researchers found that cancer patients with COVID-19 who were being administered with hydroxychloroquine with the antibiotic azithromycin drug combination to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone.

from Zee News :World https://ift.tt/2XdHMjr

• Tweet
• Share
• Share
• Share
• Share